Management of Hepatitis A in 2020-2021

JAMA. 2020 Jul 28;324(4):383-384. doi: 10.1001/jama.2020.4017.

Authors

Angel N Desai¹, Arthur Y Kim^{2

3}

Affiliations

¹ Fishbein Fellow, , Chicago, Illinois.
² Division of Infectious Diseases, Massachusetts General Hospital, Boston.
³ Harvard Medical School, Boston, Massachusetts.

PMID: 32628251
DOI: 10.1001/jama.2020.4017

No abstract available

MeSH terms

Adult
Child
Female
Hepatitis A / diagnosis*
Hepatitis A / immunology
Hepatitis A / therapy*
Hepatitis A / transmission
Hepatitis A Antibodies / analysis
Hepatitis A Vaccines / administration & dosage
Hepatitis A Vaccines / immunology
Humans
Immunization
Immunoglobulin G / analysis
Immunoglobulin M / analysis
Infant
Male
Post-Exposure Prophylaxis
Pre-Exposure Prophylaxis
Pregnancy
Sexual and Gender Minorities
Travel
Vaccines, Inactivated / administration & dosage
Vaccines, Inactivated / immunology

Substances

Hepatitis A Antibodies
Hepatitis A Vaccines
Immunoglobulin G
Immunoglobulin M
Vaccines, Inactivated